Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Cytoplasmic isocitrate dehydrogenase [NADP]

The IDH1 gene encodes a zytoplastmatic enzyme of the citrate metabolism. Genetic variants in that gene seem to be associated with glioma.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Research Method Multiplex Ligation-Dependent Probe Amplification
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Susceptibility to glioma
IDH1

References:

1.

Schnittger S et al. (2010) IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.

external link
2.

Geisbrecht BV et al. (1999) The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase.

external link
3.

Shechter I et al. (2003) IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells.

external link
4.

None (1965) ISOZYMES OF ISOCITRATE DEHYDROGENASE: SUBUNIT STRUCTURE AND INTRACELLULAR LOCATION.

external link
5.

Xu X et al. (2004) Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity.

external link
6.

Memon AA et al. (2005) Identification of differentially expressed proteins during human urinary bladder cancer progression.

external link
7.

Ronnebaum SM et al. (2006) A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion.

external link
8.

Aghili M et al. (2009) Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review.

external link
9.

Zhao S et al. (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

external link
10.

Dang L et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

external link
11.

Yan H et al. (2009) IDH1 and IDH2 mutations in gliomas.

external link
12.

Turcan S et al. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.

external link
13.

Koivunen P et al. (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.

external link
14.

Lu C et al. (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation.

external link
15.

Sasaki M et al. (2012) IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.

external link
16.

Losman JA et al. (2013) (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible.

external link
17.

Rohle D et al. (2013) An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

external link
18.

Saha SK et al. (2014) Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.

external link
19.

Schumacher T et al. (2014) A vaccine targeting mutant IDH1 induces antitumour immunity.

external link
20.

None (1973) Linkage analysis in man by somatic cell genetics.

external link
21.

Parsons DW et al. (2008) An integrated genomic analysis of human glioblastoma multiforme.

external link
22.

Dubbink HJ et al. (2009) IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.

external link
23.

Bralten LB et al. (2011) IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo.

external link
24.

Flavahan WA et al. (2016) Insulator dysfunction and oncogene activation in IDH mutant gliomas.

external link
25.

Mardis ER et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome.

external link
26.

et al. (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

external link
27.

Miller CA et al. (2013) Genomic landscapes and clonality of de novo AML.

external link
28.

Brewin J et al. (2013) Genomic landscapes and clonality of de novo AML.

external link
29.

Weil D et al. (1977) [Regional localization of the genes for human IDHs, MDHs PGK, alphaGAL, G6PD by interspecific hybridization (author's transl)].

external link
30.

Narahara K et al. (1985) Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3.

external link
31.

Boone C et al. (1972) Assignment of three human genes to chromosomes (LDH-A to 11, TK to 17, and IDH to 20) and evidence for translocation between human and mouse chromosomes in somatic cell hybrids (thymidine kinase-lactate dehydrogenase A-isocitrate dehydrogenase-C-11, E-17, and F-20 chromosomes).

external link
32.

Chen SH et al. (1972) Genetic variation of the soluble form of NADP-dependent isocitric dehydrogenase in man.

external link
33.

None (1972) Genetics of human-mouse somatic cell hybrids: linkage of human genes for isocitrate dehydrogenase and malate dehydrogenase.

external link
34.

None (1968) Intracellular location and genetic control of isozymes of NADP-dependent isocitrate dehydrogenase and malate dehydrogenase.

external link
35.

Turner BM et al. (1974) An account of two new ICD-S variants not detectable in red blood cells.

external link
36.

Creagan RP et al. (1974) Chromosome assignments of genes in man using mouse-human somatic cell hybrids: Cytoplasmic isocitrate dehydrogenase (IDH 1) and malate dehydrogenase (MDH 1) to chromosomes 2.

external link
37.

Nekrutenko A et al. (1998) Cytosolic isocitrate dehydrogenase in humans, mice, and voles and phylogenetic analysis of the enzyme family.

external link
38.

Orphanet article

Orphanet ID 299152 external link
39.

NCBI article

NCBI 3417 external link
40.

OMIM.ORG article

Omim 147700 external link
41.

Wikipedia article

Wikipedia EN (IDH1) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues